Cyclenium Pharma Inc
$350,000.00 CAD
≈ 5 Canadians' average pay for a year
- Department
- National Research Council Canada
- Program
- Eureka/Eurostar
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- June 1, 2018 – March 31, 2020
- Reference
- nrc-cnrc:172-2018-2019-Q1-907552
Published purpose
This project is focused on discovering a candidate ready for entry into formal regulatory preclinical development for the prevention and treatment of flavivirus infections by blocking an enzyme vital to the viral lifecycle with a new type of chemical structure to address the significant worldwide threat posed by these pathogens.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions